ArticlemedRxiv : the preprint server for health sciences2025
Phenome-Wide Risk Evaluation of GLP-1 Receptor Agonist Use in Type 2 Diabetes with Real-World Data Across Multiple Healthcare Systems.
Rohit Vashisht et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.